epigenetics
Cardio Diagnostics AI-Based Tests Receive Final CMS Pricing Determination
The company's two tests will be gapfilled, meaning that Medicare contractors will determine pricing for the assays based on the firm's actual cost data.
Trinity Biotech Acquiring Prostate Cancer Test Developer EpiCapture for at Least $3M
Trinity also said it had acquired a 12.5 percent equity stake in Novus Diagnostics in a deal that was worth about $2.5 million.
Delfi Diagnostics, OSF HealthCare Partner to Expand Blood-Based Lung Cancer Screening
OSF will begin offering Delfi's liquid biopsy lung cancer screening test to eligible patients, initially at 18 locations and eventually across its full network.
The company recently published data on the MESA platform's ability to screen for colorectal cancer and is considering other testing opportunities.
Cardio Diagnostics Publishes Validation Data for Molecular Coronary Heart Disease Test
The new study in the Journal of the American Heart Association shows that the firm's machine learning-based genetic-epigenetic approach can help diagnose coronary heart disease.